A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors (Q82485618)
Jump to navigation
Jump to search
scientific article published on 13 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors |
scientific article published on 13 January 2010 |
Statements
A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors (English)
Howard A Burris
Suzanne F Jones
Daphne D Williams
Steven J Kathman
Jeffrey P Hodge
Lini Pandite
Peter T C Ho
Scott A Boerner
Patricia Lorusso
13 January 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference